TABLE 5.

Inflammatory grades from baseline to Week 16 with E-BPO versus vehicle cream: Percent of patients achieving no or mild inflammation

TIME POINT	TREATMENT 1-2 (n=15)	TREATMENT 2-1 (n=16)
Baseline	0	0
Week 2	71.43	18.75
Week 4	92.85	50
Week 8	92.85	37.50
Week 12	92.86	80.00
Week 16	85.72	78.58
Range	0–92.86	0–80.00

E-BPO: microencapsulated benzoyl peroxide cream, 5%; IGA: Investigator Global Assessment